Shopping Cart
- Remove All
Your shopping cart is currently empty
Imiquimod (R 837) is an immune response modifier and a toll-like receptor 7 (TLR7) agonist with antiviral and antitumor effects. It is used in the study of external genital warts, perianal warts, cancer, and COVID-19, and is commonly employed to induce psoriasis models.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 mg | $37 | In Stock | |
| 100 mg | $50 | In Stock | |
| 200 mg | $68 | In Stock | |
| 500 mg | $113 | In Stock | |
| 1 g | $163 | In Stock |
| Description | Imiquimod (R 837) is an immune response modifier and a toll-like receptor 7 (TLR7) agonist with antiviral and antitumor effects. It is used in the study of external genital warts, perianal warts, cancer, and COVID-19, and is commonly employed to induce psoriasis models. |
| In vivo | In animal models, imiquimod stimulates the innate immune response by increasing NK cell activity, activating macrophages to secrete cytokines and nitric oxide, and inducing proliferation and differentiation of B lymphocytes. Imiquimod stimulates the innate immune response through induction, synthesis, and release of cytokines, including interferon-a (IFN-α), interleukin (IL)-6, and tumour necrosis factor (TNF)-α[1]. |
| Synonyms | S-26308, R 837, IMQ |
| Molecular Weight | 240.30 |
| Formula | C14H16N4 |
| Cas No. | 99011-02-6 |
| Smiles | C(C(C)C)N1C=2C=3C(N=C(N)C2N=C1)=CC=CC3 |
| Relative Density. | 1.28 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | H2O: Insoluble DMSO: 1.00 mg/mL (4.16 mM), Sonication and heating are recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
| |||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.